Edition:
United Kingdom

Champions Oncology Inc (CSBR.OQ)

CSBR.OQ on NASDAQ Stock Exchange Capital Market

3.98USD
15 Dec 2017
Change (% chg)

$-0.01 (-0.25%)
Prev Close
$3.99
Open
$4.00
Day's High
$4.22
Day's Low
$3.98
Volume
5,019
Avg. Vol
7,255
52-wk High
$4.75
52-wk Low
$2.22

Latest Key Developments (Source: Significant Developments)

Champions Oncology Reports Record Quarterly Revenue Of $5.2 Million
Thursday, 7 Dec 2017 

Dec 7 (Reuters) - Champions Biotechnology Inc ::CHAMPIONS ONCOLOGY REPORTS RECORD QUARTERLY REVENUE OF $5.2 MILLION.Q2 REVENUE ROSE 16.7 PERCENT TO $5.2 MILLION.SEES FY 2018 REVENUE UP AT LEAST 20 PERCENT.CHAMPIONS BIOTECHNOLOGY INC - REITERATED EXPECTATIONS FOR FISCAL YEAR 2018 REVENUE GROWTH OF AT LEAST 20% OVER FISCAL YEAR 2017.CHAMPIONS BIOTECHNOLOGY INC - QTRLY LOSS PER SHARE $0.01.CHAMPIONS BIOTECHNOLOGY - REITERATES POSITION THAT "IT DOES NOT CURRENTLY INTEND TO RAISE CAPITAL IN THE EQUITY MARKET".  Full Article

Champions Oncology posts Q3 adj. loss per share $0.11
Thursday, 16 Mar 2017 

Champions Biotechnology Inc : Champions Oncology reports 40 pct revenue growth . Q3 revenue rose 39.7 percent to $3.6 million . For Q3 of fiscal 2017, champions reported a loss from operations of $1.4 million . Qtrly non-GAAP loss per share $ 0.11 . Qtrly GAAP loss per share $0.13 . Qtrly non-GAAP loss per share $0.11 .Champions Biotechnology Inc - company ended quarter with $3.5 million of cash and cash equivalents on balance sheet.  Full Article

Champions Oncology announces pricing of public offering of common stock
Friday, 10 Jun 2016 

Champions Oncology Inc : Offering 2 million registered shares of its common stock at an offering price of $2.25 per share .Champions Oncology Inc. announces pricing of public offering of common stock.  Full Article

No consensus analysis data available.